Literature DB >> 10864615

Isolated finger flexion: a novel form of focal neuromyotonia.

H Modarres1, M Samuel, F Schon.   

Abstract

Two almost identical elderly women are described who presented with gradually progressive painless involuntary flexion of the ring and middle fingers over 12 months, leading eventually to contractures. The flexion deformity persisted during sleep and was the sole neurological abnormality. Both patients had advanced chronic obstructive pulmonary disease and were on long term salbutamol and oxygen. Neurophysiological studies indicated that this was due to neuromyotonia mainly involving flexor digitorum superficialis muscles without evidence of underlying peripheral neuropathy, proximal conduction block, or generalised neuromyotonia. Voltage gated potassium channel antibodies were negative. The clinical and neurophysiological picture remained static over a 2 year follow up period. It is suggested that this is a novel form of acquired focal neuromyotonia and speculate both on its cause and distribution.

Entities:  

Mesh:

Year:  2000        PMID: 10864615      PMCID: PMC1737009          DOI: 10.1136/jnnp.69.1.110

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  4 in total

1.  Focal neuromyotonia: do I love you?

Authors:  A R Gantenbein; M Wiederkehr; C Meuli-Simmen; G Schwegler
Journal:  J Neurol       Date:  2010-06-09       Impact factor: 4.849

2.  Reversible Focal Neuromyotonia in SLE.

Authors:  Boby Varkey Maramattom
Journal:  Ann Indian Acad Neurol       Date:  2020-06-10       Impact factor: 1.383

3.  Segmental neuromyotonia.

Authors:  Ajay Panwar; Vivek Junewar; Ritesh Sahu; Rakesh Shukla
Journal:  J Neurosci Rural Pract       Date:  2015 Jul-Sep

4.  Focal neuromyotonia as a presenting feature of lumbosacral radiculopathy.

Authors:  Tushar Premraj Raut; Ravindra Kumar Garg; Tejendra Singh Chaudhari; Hardeep Singh Malhotra; Maneesh Kumar Singh
Journal:  Ann Indian Acad Neurol       Date:  2013-10       Impact factor: 1.383

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.